Skip to main content

Table 1 Characteristics of the study participants ≥ 18 years of age, NHANES III DNA bank, 1991-1994, stratified by chronic kidney disease (CKD) status.

From: CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey

Characteristics

Total (n = 5955)

§ CKD (n = 1175)

No CKD (n = 4780)

p-value

Age, median (IQR) years

42 (30, 62)

67 (48,77)

38 (28,48)

<0.0001

Gender (males) (%)

44

42

44

0.01

Race/Ethnicity (%)

   

0.02

Non-Hispanic White % (n)

39% (2338)

47% (556)

37% (1782)

 

Non-Hispanic Black % (n)

28% (1649)

25% (293)

28% (1356)

 

Mexican American % (n)

28% (1685)

23% (272)

30% (1413)

 

Others % (n)

5% (283)

5% (54)

5% (229)

 

Serum Creatinine, mg/dL, median (IQR)

1 (0.9, 1.2)

1.2 (1,1.4)

1 (0.9,1.2)

<0.0001

Median eGFR ml/min/1.73 m2 (IQR)

93 (78, 109)

66 (53,87)

88 (77,104)

<0.0001

Urine albumin to creatinine ratio (IQR)

5.38 (2.66, 11.79)

35 (17, 87)

4 (21,74)

<0.0001

Albuminuria

   

<0.0001

None, % (n)

84% (5004)

19% (224)

100% (4780)

 

Microalbuminuria, % (n)

14% (813)

69%(813)

0 (0)

 

Macroalbuminuria, % (n)

2% (138)

12%(138)

0 (0)

 

Any form of albuminuria, % (n)

16% (951)

81%(951)

0 (0)

 

Low GFR

    

GFR < 60 ml/min (%)

7

35

0

<0.0001

CKD stage III (eGFR 30-59 ml/min) (%)

6.5

3

0

 

CKD stage IV (eGFR 15-29 ml/min) (%)

0.4

1

0

 

CKD stage V (eGFR < 15 ml/min) (%)

0.1

1

0

 

Systolic BP median (IQR), mmHg

119 (108, 134)

136 (120, 155)

117 (108,129)

<0.0001

Diastolic BP median (IQR), mmHg

62 (64, 80)

74 (66, 83)

72 (65,79)

0.07

Hypertension, %

22

46

15

<0.0001

BMI, median (IQR)

26.5 (23, 30)

27 (24, 31)

26 (23, 30)

0.02

C-reactive protein level (%)

   

<0.0001

<0.22 mg/dl (%)

62

53

65

 

0.22-0.99 mg/dl (%)

29

34

27

 

>1.00 mg/dl (%)

9

13

7

 

Current Smoking (%)

20

18

19

0.002

Prevalent CHD, (%)

8

19

4

<0.0001

LDL median (IQR),, mg/dL

122 (99, 146)

133 (106, 157)

120 (98, 144)

0.13

Diabetes (%)

11

26

7

<0.0001

  1. *Categorical variables were tested using the Cochran-Mantel-Haenszel Test and continuous variables were tested using the Taylor Linearization method with SUDAAN. All tests were weighed.
  2. § CKD defined as either by decrease glomerular filtration rate (eGFR) or by the presence of albuminuria